Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02683681 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HF Tissue Registry

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since May 23, 2024, no change to tracked fieldsv7-v8
  2. Primary and study completion dates: Dec 2021 to Dec 31, 2036v6
  3. Primary and study completion dates: Dec 2020 to Dec 2021v5
  4. 2 versions Re-verified since Jul 10, 2018, no change to tracked fieldsv3-v4
  5. Collaborators revised (2)v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a registry study. This is an observational, non-randomized, open, long-term project to collect biological samples (e.g. tissue and blood samples) in addition to clinical information and laboratory test results, from end-stage patients who undergo LVAD implantation and/or heart transplantation. There are no investigational treatments, drug or procedures associated with participation in registry activities. Data collection will not immediately influence the course of treatment for any patient.
Trial Details
NCT Number NCT02683681
Lead Sponsor Intermountain Health Care, Inc.
Collaborators: University of Utah, Center for Molecular and Genetic Research, LDS Hospital Cardiovascular Genetics Lab
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov